Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
07/07/2011 | US20110166107 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
07/07/2011 | US20110166104 Boron-containing small molecules |
07/07/2011 | US20110166103 Boron-containing small molecules |
07/07/2011 | US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
07/07/2011 | US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof |
07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
07/07/2011 | US20110165245 Compositions and methods for distraction osteogenesis |
07/07/2011 | US20110165218 Therapeutic Bone Growth and Regeneration |
07/07/2011 | US20110165215 Cohesive osteogenic putty and materials therefor |
07/07/2011 | US20110165211 Carbon dioxide external preparation, and material for formation of carbon dioxide external preparation |
07/07/2011 | US20110165200 Novel hydrogels and uses thereof |
07/07/2011 | US20110165199 Composition and Process for Bone Growth and Repair |
07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
07/07/2011 | US20110165156 Antibodies against human csf-1r and uses thereof |
07/07/2011 | US20110165144 Methods for treating rheumatoid arthritis |
07/07/2011 | US20110165132 Heparan Sulphate Which Binds BMP2 |
07/07/2011 | US20110165122 Method for targeted and sustained antiviral therapy |
07/07/2011 | US20110165116 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
07/07/2011 | US20110165066 Interleukin-13 binding proteins |
07/07/2011 | US20110165063 Il-1 binding proteins |
07/06/2011 | EP2341143A1 OX2 receptor homolog |
07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
07/06/2011 | EP2341048A1 Thiazolium salt compound and the use of treating the protein aging disease |
07/06/2011 | EP2340849A1 Anti-NGF antibodies for the treatment of various disorders |
07/06/2011 | EP2340841A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient |
07/06/2011 | EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
07/06/2011 | EP2340039A1 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis |
07/06/2011 | EP1763362B1 Use of op-1 for treating cartilage defects |
07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
07/06/2011 | CN1903220B Health-care food with function of improving skeletal density and its prepn. method |
07/06/2011 | CN102119174A Compositions and methods of use for therapeutic antibodies |
07/06/2011 | CN102119160A Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
07/06/2011 | CN102119138A Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
07/06/2011 | CN102115721A Lactobacillus isolated strains with anti-inflammatory activity and use thereof |
07/06/2011 | CN102114271A Multi-medicament loaded calcium phosphate cement powder |
07/06/2011 | CN102114245A Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof |
07/06/2011 | CN102114225A Traditional Chinese medicine for treating gout of diabetes patient |
07/06/2011 | CN102114220A Quality control method for Chinese medicinal preparation for treating traumatic injuries and rheumatoid sacrodynia |
07/06/2011 | CN102114215A Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof |
07/06/2011 | CN102114212A Traditional Chinese medicine for treating diabetic gout |
07/06/2011 | CN102114204A Traditional Chinese medicine formula for treating gout |
07/06/2011 | CN102114165A Plaster for treating pain of cervical and lumbar vertebrae and preparation method thereof |
07/06/2011 | CN102114146A Oral Chinese medicinal liquor for treating wind chill leg pain |
07/06/2011 | CN102114091A Externally-applied paste for treating fracture |
07/06/2011 | CN102114088A Chinese medicine preparation for treating bone fracture |
07/06/2011 | CN102114078A Chinese medicine extract for promoting fracture healing and preparation method and application thereof |
07/06/2011 | CN102114070A Compound traditional Chinese medicine for treating osteoporosis and preparation method thereof |
07/06/2011 | CN102114025A Pharmaceutical composition for treating osteoporosis |
07/06/2011 | CN102113996A Oral formulations containing protein or peptide, and preparation method and application thereof |
07/06/2011 | CN102113984A Composite with function of reducing weight of abdomen |
07/06/2011 | CN102113932A Multifunctional saline-alkaline heat transfer treatment baking bed and preparation method thereof |
07/06/2011 | CN101837080B Topical ointment externally used for treating cervical spondylosis |
07/06/2011 | CN101708166B Cefpodoxime proxetil submicron emulsion solid preparation and novel application thereof |
07/06/2011 | CN101278953B Externally-applied medicine for curing hydrarthrosis of knee and method of processing the same |
07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
07/06/2011 | CN101052397B 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
07/05/2011 | US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors |
07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
07/05/2011 | US7973031 Leukemia therapy ;myelodyspastic syndrome |
07/05/2011 | US7973024 24-sulfoximine vitamin D3 compounds |
07/05/2011 | US7973010 Full length polynucleotide coding chicken type II collagen and the use of it |
07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
07/05/2011 | US7972630 Injectable bone mineral substitute material |
07/05/2011 | CA2531484C Novel bioisosteres of actinonin |
07/05/2011 | CA2486728C Novel physiologically active substances useful for suppressing vegf production |
07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
06/30/2011 | WO2011079103A1 Spiropiperidine benzylamines as beta-tryptase inhibitors |
06/30/2011 | WO2011079076A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors |
06/30/2011 | WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
06/30/2011 | WO2011078799A1 Treatment of bone fracture |
06/30/2011 | WO2011078795A1 Bridged morpholino substituted purines |
06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
06/30/2011 | WO2011077159A1 Treatment of osteoporosis |
06/30/2011 | WO2011076880A1 Methods and use related to humanin and humanin-like peptides |
06/30/2011 | WO2011076596A1 A combination for the treatment of osteoarthritis |
06/30/2011 | WO2011011706A3 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
06/30/2011 | US20110160642 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
06/30/2011 | US20110160298 Pharmaceutical composition for prevention and/or treatment of bone loss |
06/30/2011 | US20110160296 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine |
06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
06/30/2011 | US20110160273 Co-crystals of duloxetine and cox-inhibitors for the treatment of pain |
06/30/2011 | US20110160270 Deuterium-enriched sdx-101 |
06/30/2011 | US20110160256 Inhibitors of akt activity |
06/30/2011 | US20110160255 Inhibitors of akt activity |
06/30/2011 | US20110160235 Triazolyl tropane derivatives |
06/30/2011 | US20110160234 Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors |
06/30/2011 | US20110160232 Certain chemical entities and therapeutic uses thereof |
06/30/2011 | US20110160229 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia |